Cargando…
Racemic vs. enantiopure inert Ti(iv) complex of a single diaminotetrakis(phenolato) ligand in anticancer activity toward human drug-sensitive and -resistant cancer cell lines
A tetrakis(phenolato) Ti(iv) complex was synthesized in racemic and optically pure form, exhibiting high hydrolytic stability, and similar cytotoxicity for all stereochemical forms on HT-29 and A2780 cancer cells. Higher activity of the racemate on drug-resistant A2780cp and A2780adr lines implies a...
Autores principales: | Miller, Maya, Tshuva, Edit Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333245/ https://www.ncbi.nlm.nih.gov/pubmed/30713687 http://dx.doi.org/10.1039/c8ra08925f |
Ejemplares similares
-
In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells
por: Ganot, N., et al.
Publicado: (2018) -
Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity
por: Miller, Maya, et al.
Publicado: (2018) -
In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs
por: Ganot, Nitzan, et al.
Publicado: (2018) -
Racemic and Enantiopure Camphene and Pinene Studied
by the Crystalline Sponge Method
por: de Poel, Wester, et al.
Publicado: (2017) -
Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity
por: Meker, Sigalit, et al.
Publicado: (2015)